Year: 2023

Tonix Pharmaceuticals Presents New Preclinical Data at Seventh International Cancer Immunotherapy Conference 2023

mTNX-1700 (mTFF2-MSA) suppresses tumor growth and increases survival rates in preclinical colorectal cancer models mTNX-1700 shows single agent activity and...

Entrada Therapeutics Announces First Participant Dosed in its Phase 1 Clinical Trial of ENTR-601-44 for the Potential Treatment of Duchenne Muscular Dystrophy

– Initiation of Phase 1 clinical trial marks Entrada’s transition into a clinical company – – Data anticipated in the...

Riverside University Health System to Implement FloPatch by Flosonics, Revolutionizing Precision Fluid Management in Sepsis Care

RIVERSIDE, Calif.--(BUSINESS WIRE)--#flopatch--Riverside University Health System is proud to announce the implementation of FloPatch by Flosonics Medical. As a pioneer...

Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced that researchers...

error: Content is protected !!